Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v60-FR Version v45-EN
Language French English
Date Updated 2022-02-15 2018-07-25
Drug Identification Number 02404184 02404184
Brand name MYLAN-TOLTERODINE ER MYLAN-TOLTERODINE ER
Common or Proper name TOLTERODINE ER TOLTERODINE ER
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients TOLTERODINE TARTRATE TOLTERODINE TARTRATE
Strength(s) 2MG 2MG
Dosage form(s) CAPSULE (EXTENDED RELEASE) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 100BT, 30BT 100BT, 30BT
ATC code G04BD G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-10-10 2017-10-10
Actual start date 2017-10-10 2017-10-10
Estimated end date Unknown 2018-10-31
Actual end date 2022-02-14
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Last lot 3079138, Expiry August-31-2018
Health Canada comments